Mutations in the BCR-ABL1 Kinase Domain and Elsewhere in Chronic Myeloid Leukemia

Title
Mutations in the BCR-ABL1 Kinase Domain and Elsewhere in Chronic Myeloid Leukemia
Authors
Keywords
BCR-ABL1, mutations, Dasatinib, Imatinib, Nilotinib, Tyrosine kinase inhibitor
Journal
Clinical Lymphoma Myeloma & Leukemia
Volume 15, Issue -, Pages S120-S128
Publisher
Elsevier BV
Online
2015-08-19
DOI
10.1016/j.clml.2015.02.035

Ask authors/readers for more resources

Reprint

Contact the author

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now